Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors


CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced it has appointed Jacqualyn (“Jackie”) Fouse, Ph.D. to its Board of Directors. Fred Craves, Ph.D. is retiring from the Board in July 2025.

Continue reading here:
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors

Related Posts